LPL Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LPL Financial's XBI Position: Q1 2026 in Review
LPL Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.5% in Q1 2026, selling an estimated $10.4M and leaving 792,546 shares worth $101M. The position accounts for 0.03% of the portfolio, ranked #574.
LPL Financial first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- LPL Financial held 792,546 shares of State Street SPDR S&P Biotech ETF worth $101M as of Q1 2026.
- LPL Financial sold 83,001 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.4M.
- State Street SPDR S&P Biotech ETF made up 0.03% of LPL Financial's portfolio in Q1 2026, its #574 holding.
- LPL Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- LPL Financial's State Street SPDR S&P Biotech ETF position peaked at $107M in Q4 2025.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.